Can Removing “Zombie Cells” Slow Aging? Human Clinical Trials Are Starting to Deliver Answers

Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer’s, and frailty. Here is an honest account of what 80-plus trials are finding.